Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 18 Years or older~* Males or Females~* Primary diagnosis of TBI, subarachnoid hemmorhage (SAH), intracranial hemmorhage (ICH), stroke~* Requires mechanical ventilation~* Requires or is receiving continuous IV sedation~Exclusion Criteria:~* Glascow Coma Score (GCS) of 3 persisting from the scene with bilaterally fixed dilated pupils with no appreciable chance of survival~* The inability to identify a next of kin or guardian to give consent if patient unable to consent~* Pregnant~* Allergy or contraindication to propofol~* Allergy to contraindication to midalozam~* Status epilepticus~* Current neuromuscular blockade~* Patient with a known hypersensitivity to propofol or midalozam~* Allergies to eggs, egg products, soybeans or soy products~* Acute narrow-angle glaucoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous sedation with propofol (Type: ACTIVE_COMPARATOR): Traumatic brain injured patient, already requiring sedation. Intervention is sedation with intravenous propofol during mechanical ventilation
- Intravenous sedation with midazolam (Type: ACTIVE_COMPARATOR): Patients with traumatic brain injury requiring mechinical ventilation. Intervention is intravenous midazolam for sedation at variable doses to achieve adequite sedation levels

Based on this trial design, predict the completion outcome and termination type (if applicable).